Teladoc Health, Inc.TDOCNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank92
3Y CAGR+9.6%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+9.6%/yr
Annual compound
Percentile
P92
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$227.57M-19.6%
2024$282.89M+46.1%
2023$193.67M+12.1%
2022$172.81M-6.8%
2021$185.46M+333.1%
2020$-79.55M-519.4%
2019$18.97M+243.0%
2018$-13.27M+66.8%
2017$-39.96M+27.6%
2016$-55.21M-